A. Olaye

Polymer carriers for drug delivery in tissue engineering.

K. Shakesheff, M. Sokolsky-Papkov, K. Agashi, 2007, Advanced drug delivery reviews.

Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2)

A. Olaye, W. Ghosh, P. Gissen, 2021, Orphanet Journal of Rare Diseases.

A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases

J. Kleijnen, C. Hendriksz, A. Olaye, 2014, Orphanet Journal of Rare Diseases.

Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2]

O. Solà-Morales, A. Olaye, H. Telser, 2021, Expert review of pharmacoeconomics & outcomes research.

Economic Modeling Considerations for Rare Diseases.

A. Olaye, C. Knight, I. Pearson, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The Challenges of Living with and Caring for a Child or Children Affected by Neuronal Ceroid Lipofuscinosis Type 2 Disease: In-Depth Family Surveys in the United Kingdom and Germany

A. Olaye, T. Peasgood, L. Eliasson, 2020, Journal of Inborn Errors of Metabolism and Screening.

Relationship Between Patient-Reported Outcomes and Clinical Outcomes in Patients With Morquio A Syndrome

Christina Lampe, Eugen Mengel, A. Olaye, 2015 .

A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcel

A. Olaye, N. Armstrong, C. Noake, 2023, Orphanet Journal of Rare Diseases.